Compound Detail
CHEMBL1257030
LONIDAMINE 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL1257030 |
| Name | LONIDAMINE |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | WDRYRZXSPDWGEB-UHFFFAOYSA-N |
4
Targets
12
Activities
2
Assay Types
0
PK Parameters
20
Publications
5
Known Names
2
Indications
Molecular Properties
321.2
MW (Da)
4.09
ALogP
3
HBA
1
HBD
55.1
PSA (Ų)
0.79
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Indications
Neoplasms Prostatic Hyperplasia
ATC Classification
L01XX07
lonidamine
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS
Activity Summary
IC50 11 meas. best 5.13
Ki 1 meas. best 5.6
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | Ki | 5.6 | 5.6 | 2500.0 | 1 |
| Leucine aminopeptidase CHEMBL1293313 | IC50 | 5.13 | 5.13 | 7370.0 | 1 |
| Leishmania donovani CHEMBL367 | IC50 | 5.06 | 5.06 | 8660.0 | 1 |
| HGC-27 CHEMBL1075463 | IC50 | 4.11 | 4.11 | 77620.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | Ki | = | 2500.0 | nM | 5.6 | Inhibition of mitochondrial pyruvate carrier in Wistar rat liver mitochondria as... | 33103432 |
| Leucine aminopeptidase | IC50 | = | 7370.0 | nM | 5.13 | PUBCHEM_BIOASSAY: Inhibitors of Plasmodium falciparum M17- Family Leucine Aminop... | - |
| Leishmania donovani | IC50 | = | 8660.0 | nM | 5.06 | DNDI: Leish (axenic) in Vitro, 72 hour | - |
| HGC-27 | IC50 | = | 77620.0 | nM | 4.11 | Antiproliferative activity against human HGC-27 cells assessed as cell growth in... | 37376788 |
Literature References
Data from ChEMBL 36 via Core Engine